Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:15 AM
Ignite Modification Date:
2025-12-25 @ 2:15 AM
NCT ID:
NCT00453960
Eligibility Criteria:
Inclusion Criteria:
* Premenopausal women
* Age \> = 44 years
* Dysfunctional uterine bleeding
* No treatment with other hormonal drugs (estrogen, progesterone)
* No local or general pathology negatively influenced by administration of genistein or progesterone
* No intrauterine pathologies (polyps, myomas)
* A "non atypical endometrial hyperplasia", confirmed by hysteroscopy with biopsy and histological examination
Exclusion Criteria:
* All the other conditions
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
44 Years
Maximum Age:
55 Years
Study:
NCT00453960
Study Brief:
Protocol Section:
NCT00453960